Bill & Melinda Gates Foundation shows faith in CureVac
February 14, 2018Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical
The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
Roivant signs $600m licensing deal with Poxel
February 13, 2018Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma
Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …
Vertex gets approval for combo-therapy in cystic fibrosis
February 13, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …
Cancer-targeting nanorobots successfully starve and shrink tumours, study shows
February 13, 2018Manufacturing and Production, Research and Development Arizona State university, Cancer, Chinese Academy of Sciences, National Center for Nanoscience and Technology, nanorobots, pharma
A team of researchers from Arizona State University (ASU), in partnership with the Chinese Academy of Sciences’ National Center for …
Purdue pulls plug on opioid marketing
February 13, 2018Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …
New flu med can destroy influenza virus in one day
February 13, 2018Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical
Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
Taking a look behind the scenes of Serialisation
February 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation
The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma
February 12, 2018Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma
Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …
Sanofi in $155m influenza vaccine deal
February 12, 2018Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
Novo’s Ozempic secures European approval in type 2 diabetes
February 12, 2018Sales and Marketing EC, EMA, Europe, Novo Nordisk, diabetes, pharma
Novo Nordisk has revealed that its drug Ozempic (semaglutide) has received approval from the European Commission (EC) as a monotherapy …
Trump’s drug pricing reforms lack bite
February 12, 2018Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical
President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
Boehringer terminates Alzheimer’s candidate after Phase 2 failure
February 12, 2018Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma
Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
MannKind entices Lilly VP to CMO role
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical
MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
SFO bribery investigation into GSK opens old wounds
February 9, 2018Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …
Top Ten most popular articles on Pharmafile.com this week
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma
It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
Fujifilm partners with Takeda, stepping into regenerative medicine
February 9, 2018Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical
Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer
February 9, 2018Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma
Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …
Migraine drug bad news hits a weakened Teva
February 9, 2018Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical
The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
Stada poaches Novartis exec for fifth CEO in two years
February 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment
Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Celgene Executive Chairman Bob Hugin retires
February 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
